Serum NT-proBNP levels are a prognostic predictor in patients with advanced heart failure;O nível sérico de NT-proBNP é um preditor prognóstico em pacientes com insuficiência cardíaca avançada

Arquivos Brasileiros de Cardiologia

Volumn 87, Issue 2, 2006, Pages 174-177

  Pereira Barretto, Antonio Carlos ^a,b   De Oliveira Jr , Mucio Tavares ^a   Strunz, Célia Cassaro ^a   Del Carlo, Carlos Henrique ^a   Scipioni, Airton Roberto ^a   Ramires, José Antonio Franchini ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Advanced heart failure; BNP; Decompensated heart failure; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PROGNOSIS; SURVIVAL;

EID: 33748415872     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2006001500016     Document Type: Article

References (14)

1. McMurray JJV, Stewart S. The burden of heart failure. Eur Heart J. 2002; 4 (suppl D): 50-8.
2. Fonarow GC, Adams KF, Abraham WT, et al. Risk stratification for inhospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA. 2005; 293: 572-80.
3. Shahar E, Lee S, Kim J, et al. Hospitalized heart failure: rates and long-term mortality. J Cardiac Fail. 2004; 10: 374-8.
4. Wong PS, Davidsson GK, Timeyin J, et al. Heart failure in patients admittd to hospital: mortality is still high. Eur J Intern Med. 2002; 13: 304-10.
5. Kearney MT, Foxx KAA, Lee AJ, et al. Predicting death due to progressive heart failure in patients with mild to moderate chronic heart failure. J Am Coll Cardiol. 2002; 40: 1801-8.
6. Brophy JM, Dagenais GR, McSherry F, et al. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med. 2004; 116: 300-304.
7. Felker GM, Leiberger JD, Califf RM, et al. Risk stratification after hospitalization for decompensated heart failure. J Cardiac Fail. 2004; 10: 460-6.
8. VillaCorta H, Mesquita ET, Cardoso R, et al. Preditores de sobrevida obtidos na unidade de emergência em pacientes atendidos por insuficiência cardíaca descompensada. Rev Port Cardiol. 2003; 22: 495-507.
9. Oliveira Jr MT, Canesin MF, Munhoz RT, et al. Principais características clínicas de pacientes que sobrevivem 24 meses ou mais após uma hospitalização devido a descompensaç ão cardíaca. Arq Bras Cardiol. 2005; 84 (2): 161-6
10. Bettencourt P, Azevedo A, Pimenta J, et al. N-Terminal-ProBrain Natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004; 110: 2168-74.
11. Gardner RS, Ozalp F, Murday AJ, et al. N-Terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003; 24: 1735-43.
12. Hartmann F, Packer M, Coats AJS, et al. Prognostic impact of plasma N-Terminal pro-brain natriuretic peptide in severe chronic congestive heart failure. A sub study of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial. Circulation. 2004; 110: 1780-6.
13. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004; 43: 635-41.
14. II Diretrizes da Sociedade Brasileira de Cardiologia para o diagnóstico e tratamento da insuficiência cardíaca. Arq Bras Cardiol. 1999; 72: 1-30.